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indications for which the drug is indicated and 
the formula based on average dose does not 
stand to practical reality. It is scientific but drug 
prescribing practices are far from scientific. It 
was and is the observation of the author that all 
the diagnoses noted on the prescriptions are 
either depression and/or AN. Patients after a 
single visit, use the same on and off for 
prolonged periods. Under these circumstances 
coming to any other conclusion based on one's 
own presumptions is hazardous. Ground 
realities are far different and ignoring them will 
lead to confined conclusions. 
A thorough reading of the article will 
show newer antipsychotics, which are costly, 
had less sales so the question of costly drugs 
pushing up the sales did not arise. Further 
simple computation of data presented shows 
that the order of sales in Rs., is in agreement 
with all India sales-tranquiiiizers, including 
alprazolam, Rs. 19.38 lacs, antidepressants, in-
cluding fluoxetine, 16.35 lacs and 
antipsychotics Rs. 8.27 lacs. This indicates that 
prescribing practices are same in other parts 
of the country. 
I thank Chittaranjan Andrade for 
pointing an alternative interpretation of the data 
presented and for the pure scientific value of it. 
P. GOPALA SARMA, Prof. & Head, Department 
of Psychiatry, Warangal 506 007. 
DRUG PROPHYLAXIS OF 
SCHIZOPHRENIA ? 
Sir, 
We wish to draw attention of the 
readers of your prestigious journal to the 
aspect of drug prevention of schizophrenia. This 
becomes more relevant as the market for newer 
antipsychotic drugs especially atypical ones 
may expand in view of ideas expressed at 
recently concluded 6th world Congress of 
Biological Psychiatry in Nice. According to Prof. 
Patrick McGorry of Melbourne University, 
prophylactic or preventive treatment of pre 
schizophrenics with neuroleptics could become 
an important area. He says 43% of individuals 
with a certain cluster of risk factors (genetic 
loading, psychosocial dysfunction and paranoia) 
may become psychotic within 12 months (Prod-
ucts, 1997). The so called prodromal symptoms 
may develop many years before fullfledged 
positive symptoms such as delusions and hal-
lucinations appear. These combined with lack 
of motivation, initiative and decreased emo-
tional responsiveness to external stimuli in 
surroundings resemble more closely to 
negative symptoms. These features have also 
been described in simple schizophrenia. Do 
negative symptoms precede positive symptoms 
? This is another question worth investigation. 
But in this context prevention of schizophrenia 
with atypical neuroleptics, though controversial, 
could become pertinent. Eli Lilly in 
collaboration with National Institute of Mental 
Health have planned to initiate treatment with 
olanzapine to delay or even prevent the onset 
of disease. However, the continuing advance 
in understanding of genetics of the disease 
would help in identification of persons at rela-
tive risk with greater accuracy. But in our view 
such prepositions where neuroleptic drugs shall 
be used over a prolonged period there are two 
major limitations-first precipitation of 
psychosis and second appearance of side 
effects. 
There is evidence that increased 
dopamine (DA) receptor binding sites in the 
neostriatum and this alongwith DA 
supersensitivity due to chronic receptor 
blockade are responsible for tardive dyskinesia 
(Burt et al., 1977). Similarly after chronic 
exposure to neuroleptics, there may be an 
increase in DA receptor binding sites in 
mesolimbic area as well. This could result in 
the appearance of psychotic symptoms when 
neuroleptic medication is withdrawn, decreased 
or even held at constant dosage for a certain 
period of time. There is an evidence that 
psychosis can develop in patients suffering from 
nonpsychotic disorder treated with neuroleptic 
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drugs or withdrawn from neuroleptic drugs even 
though they have never been psychotic in their 
lifetime. This neuroleptic induced psychosis 
(withdrawal and tardive psychosis) is separate 
from illness related psychosis (Chouinard et al., 
1978). However, it could become difficult to 
differentiate between these two entities 
especially when an individual is receiving 
neuroleptic for a prolonged period of time. The 
two important aspects in relation to long term 
drug therapy are for how long and in what 
dosage. However it is difficult to predict time 
course of neuroleptic exposure which would 
render an individual susceptible for 
development or precipitation of psychosis and 
also to find a dose level which would produce 
intended prophylactic effect without enhancing 
the DA receptor binding sites. 
Further, atypical neuroleptic drugs may 
affect the dopamine receptors differently and 
as they have been claimed to produce no or 
minimal extrapyramidal effects, their 
propensity to increase DA receptor sites in 
mesolimbic area could also be less than typical 
neuroleptic drugs (Farde et a]., 1992). In that 
case the treatment of preschizophrenics, if 
proven effectively in controlled clinical trials, 
would be a useful proposition. 
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THE KLINGSOR SYNDROME 
Sir, 
Self injurious behaviour (SIB) has been 
defined as repetitive, deliberate, direct 
physical harm without a conscious suicidal 
intent that does not lead to evidently life 
threatening wounds (Bennun, 1984; Favazza, 
1989). General self mutilation is very rare. 
Klingsor syndrome (Schweizer, 1990) is the 
eponym suggested for the acts of genital self 
mutilation involving religious delusions. 
A 22 years old, right handed, unmarried, 
hindi speaking muslim male, hailing from a 
lower socioeconomic status from U.P. was 
admitted in the urology department with self 
inflicted traumatic amputation of the penis (com-
plete and proximal to the corona) and altered 
behaviour of 4-5 days duration prior to hospi-
talization. The altered behaviour was of sud-
den onset after the patient had visited a 
disturbed area in Mumbai for work purposes. 
At that time some muslim men accosted him 
and told him not to be seen in that locality again. 
After this incident the patient became fearful, 
started hearing voices belonging to the devil 
and Allah which would tell him that he was not 
a true muslim. The patient also started think-
ing that since he was not a true muslim his fa-
ther would take him for circumcision again. The 
patient then cut off his penis on the night prior 
to admission. He felt no pain at that time. Next 
morning he was found in a pool of blood by his 
father who then brought him to the hospital. 
Other features included poor sleep, ap-
petite and neglect of self care. Symptoms 
suggestive of mood disorder, anxiety and OCD 
were not present. There was no evidence of 
organic features or any other physical illnesses 
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